PATIENT S NOTES History and Physical Brain Attack Stroke

Similar documents
Get With the Guidelines Stroke PMT. Quality Measure Descriptions

ACCESS CENTER:

TENNESSEE STROKE REGISTRY QUARTERLY REPORT

The Importance of Stroke Programs in an Acute Care Setting by Debbie Estes, RN, BSN Stroke Program Coordinator, Medical City of Dallas

New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.1

GWTG Post-Discharge Follow-up Form

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival

CEREBRO VASCULAR ACCIDENTS

Primary Stroke Center Quality & Performance Measures

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08)

TENNESSEE STROKE REGISTRY QUARTERLY REPORT

Stroke Transfer Checklist

Diagnosis: Allergies with reaction type:

ED Stroke Panel Page 1 of 2

Supplementary Online Content

o Unenhanced Head CT

Thrombolysis Assessment

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

Acute Stroke with Alteplase Administration Order Set

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1)

DRUG ALLERGIES WT: KG

Stroke Guidelines. November 19, 2011

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Stroke in the Rural Setting: How You Can Make A Difference. Susie Fisher, RN, BSN Program Manager Providence Stroke Center Portland, OR

Select one option. Unknown

Stroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP

CONCISE GUIDE National Clinical Guidelines for Stroke 2nd Edition

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Acute Stroke Protocols Modified- What s New in 2013

Emergency Department Management of Acute Ischemic Stroke

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist

AGWS Stroke Thrombolysis Clinical Profoma

ALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked DRUG AND TREATMENT ORDERS

2018 Early Management of Acute Ischemic Stroke Guidelines Update

Do Not Cite. Draft for Work Group Review.

convey the clinical quality measure's title, number, owner/developer and contact

Emergency Room Procedure The first few hours in hospital...

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Multidisciplinary Geriatric Trauma Care Guideline

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center

Endovascular Neurointervention in Cerebral Ischemia

Variables in Riksstroke - TIA

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Practical Considerations in the Early Treatment of Acute Stroke

<INSERT COUNTRY/SITE NAME> All Stroke Events

2017 Stroke Statistics

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

TABLE OF CONTENTS. MODULE 1: Pathophysiology of Stroke, Neuroanatomy, and Stroke Syndromes. MODULE 2: Acute Stroke Management

2016 Stroke Statistics

TIA: Updates and Management 2008

Basilar artery stenosis with bilateral cerebellar strokes on coumadin

BY: Ramon Medina EMT-LP/RN

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS:

GERIATRICS CASE PRESENTATION

Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study

Acute Stroke Management LUKE BRADBURY, MD 10/8/14 FALL WAPA CONFERENCE

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

Disclosure Statement: Dr. Knoefel has nothing to disclose

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Shands at the University of Florida Stroke Program

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Marcey Osgood, DO Assistant Professor of Neurocritical Care UMASS Medical Center

Headline. Objectives. Baptist Health Mission Stroke Core Measures

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

2015 Update in Diagnosis and Management of Stroke

Stroke Quality Measures. Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: December 2012

Stroke ESO.org. Csiba László.

WAIS AFZAL, MD. PGY-1 Department of Internal Medicine Jamaica Hospital Medical Center

Long-Term Care Updates

Endovascular Treatment Updates in Stroke Care

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Dental Management Considerations for Patients on Antithrombotic Therapy

Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY

Standards of excellence

Department Specific Guideline

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

Alan Barber. Professor of Clinical Neurology University of Auckland

Stroke Belt Consortium

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

2012 Core Measures. Acute Myocardial Infarction (AMI)

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

what do the numbers really mean? NIHSS Timothy Hehr, RN MA Stroke Program Outreach Coordinator Allina Health

The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial

2018 Update in Diagnosis and Management of Stroke

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Epidemiology and Prevention of Stroke

2014 Update in Diagnosis and Management of Stroke

3. Screening Subject Identification Screening Overview

Transcription:

UNIVERSITY HOSPITALS OF CLEVELAND PATIENT S NOTES History and Physical Brain Attack Stroke 040527.01 page 1 of 8 Name Hospital # Date Sex Age Dr. Service Division Rm No Date and Time: Current inpatient at UHC: Chief complaint: Consultation per service Admitted through ED (see also below) Transferred from another acute care hospital History of acute illness: Admit from chronic care/snf/rehab facility Admit from home Other Time course: onset of symptoms: Is time of onset when pt last known normal? Time arrived at other ED: Time arrived at UH ED: Time first seen by ED MD: Yes No Witnessed Self-reported Awoke with sx Sx while awake Arrival mode: EMS from scene to ED Private/walk-in to ED EMS hosp trfr to ED Did not present via ED Functional status prior to current presentation (modified Rankin scale): 0 No symptoms 1 No significant disability 2 Slight disability 3 Moderate disability 4 Moderately severe disability 5 Severe disability

Page 2 of 8 Past medical history: Allergies: Yes no Prior TIA or stroke Carotid stenosis CAD/prior MI/angina Atrial fibrillation Valvular heart disease Prosthetic heart valve CHF Peripheral vascular disease Diabetes Hypertension Hyperlipidemia Renal insufficiency Sedentary lifestyle Obesity GI bleeding Medications at home: Anticoagulants/Antiplatelets Antihypertensives Cholesterol reducers Diabetes medication Review of systems: Other pos neg Constitutional Psychiatric Eyes ENT Cardiovasc Respiratory GI GU Musculoskeletal Integument Heme/Lymphatic Allergic/Immunologic Endocrine Family history: yes no Stroke at young age Coronary artery disease Other Social History: yes no Smoking in past year Alcohol occasional Alcohol regularly Drug abuse

UNIVERSITY HOSPITALS OF CLEVELAND PATIENT S NOTES Brain Attack Stroke 040527.01 page 3 of 8 Name Hospital # Date Sex Age Dr. Service Division Rm No General Physical Examination: BP: / Resp: HR: Wt: Ht: Temp: O 2 sat % on Neurologic exam: Level of consciousness: alert 0 drowsy 1 stuporous 2 comatose 3 LOC question: LOC commands: both correct 0 one correct 1 neither correct 2 obeys both 0 obeys one 1 obeys neither 2 Left upper extremity: no drift (10 sec) 0 drift 1 effort vs gravity 2 no effort vs gravity 3 no movement 4 Left lower extremity: no drift (5 sec) 0 drift 1 effort vs gravity 2 no effort vs gravity 3 no movement 4 Best language: Dysarthria: Best gaze: Visual field: Neglect: Facial paresis: no aphasia 0 mild-mod aphasia 1 severe aphasia 2 mute 3 normal 0 mild-moderate 1 unintelligible 2 normal 0 partial gaze palsy 1 forced deviation 2 no visual loss 0 partial HH 1 complete HH 2 bilateral 3 none 0 partial 1 complete 2 normal 0 minor paresis 1 complete UMN 2 complete LMN 3 Right upper extremity: no drift (10 sec) 0 drift 1 effort vs gravity 2 no effort vs gravity 3 no movement 4 Right lower extremity: no drift (5 sec) 0 drift 1 effort vs gravity 2 no effort vs gravity 3 no movement 4 Limb ataxia: Sensory: absent 0 present 1 limb 1 present 2 limbs 2 absent 0 partial loss 1 dense loss 2 Total NIHSS score:

Page 4 of 8 Imaging studies: CT scan time done @ OSH @ UHC initial CT old disease: initial CT new disease: MRI scan time done @ OSH @ UHC MRI result: circulation territory: Labs: Total cholesterol: Hgb A1C: Triglycerides: Ca HDL: CPK: Mg PT PTT INR LDL: Troponin: PO 4 EKG: CXR: Thrombolytic Therapy Decision: None IV IA If not, why not: Delay in patient arrival (>3 hrs after onset of stroke symptoms) Hx of ICH, brain aneurysm, vasc malformation, or brain tumor Other time delay age Uncontrolled hypertension active internal bleeding (<22 days) Rapid improvement platelet count < 100,000 CT findings abnormal PTT or PT Stroke severity too mild glucose <50mg/dL or >400mg/dL Stroke severity too severe no IV access Seizure at onset life expectancy <1 yr or severe co-morbid illness Recent surgery/trauma (<15 days) IV t-pa given at outside hospital prior to transfer Recent intracranial surgery, head trauma, or stroke (3 months) Investigational protocol instead of IV t-pa Patient/family refused (eg DNR/CMO) Other reason Consent not obtainable Not documented Therapy, if not tpa:

UNIVERSITY HOSPITALS OF CLEVELAND PATIENT S NOTES Brain Attack Stroke 040527.01 page 5 of 8 Name Hospital # Date Sex Age Dr. Service Division Rm No IV Thrombolysis: Time started: Last BP prior to (IV) tpa: Where started: Narrative of clinical course Immediately apparent complications: None Symptomatic intracranial hemorrhage Life-threatening serious systemic hemorrhage IA Thrombolysis: Angio time: Last BP prior to (IA) tpa: Initial findings: Carotid stenosis Yes No If yes, is intervention considered/performed? Narrative of IA thrombolysis Time Quantity Location BP@infusion Total amt rtpa: Recanalization: Yes No Partial None Immediately apparent complications: Symptomatic intracranial hemorrhage Life-threatening serious systemic hemorrhage

Page 6 of 8 Assessment: Check here if not acute ischemic stroke Co-morbid conditions: Hypertension Diabetes Hyperlipidemia Other (list) Plan (check relevant items and specify): Antiplatelet agent Anticoagulation Neuroprotective measures BP Glucose Temperature Screening for dysphagia prior to oral intake DVT prophylaxis GI prophylaxis Aspiration precautions PT/OT/ST Goal LDL < 100 Further studies (specify) Counseling re risk factor modification Information sheet given to patient ER resident: Brain attack attending: Ward resident: Ward or consult attending: Senior resident: if BAT fax to 4-7443 MD Signature:

UNIVERSITY HOSPITALS OF CLEVELAND PATIENT S NOTES Brain Attack Stroke 040527.01 page 7 of 8 Name Hospital # Date Sex Age Dr. Service Division Rm No Summary of hospital course and follow-up: Admit date: NIHSS @ admission: Discharge date: NIHSS @ 24hrs: NIHSS @ discharge: Final diagnosis: Ischemic stroke If ischemic: TIA cardioembolism SAH Small vessel dz ICH Large artery atherosclerosis Uncertain type Stroke of other determined etiology Stroke of uncertain etiology Narrative summary: Complications during hospital course: Intracranial hemorrhage GI bleeding GU bleeding Pneumonia (treated? Yes/No) Discharge functional status: Discharge destination: 01: discharged to home or self care (routine) 02: to another short term general hospital for inapatient care 03: to skilled nursing facility (SNF) with medicare certification 04: to an intermediate care facility (ICF) 05: to another type of institution for inpatient care 06: to home under care of home health service organization 07: left against medical advice or discontinued care 08: to home under care of home IV drug therapy provider Able to ambulate alone (with or without device) Ambulate with assist from other person(s) Not able to ambulate 20: expired (or did not recover Christian Science pt) 41: expired in medical facility (eg hospital, SNF, ICF, hospice) 50: hospice home 51: hospice medical facility 61: within this institution to medicare approved swing bed 62: to inpatient rehab facility (IRF) 63: to medicare certified long term care hospital (LCTH) 64: to nursing facility Medicaid not medicare

Page 8 of 8 DVT prophylaxis: Patient ambulating without assistance from another person on 2 nd day? Yes No If patient not ambulating, was DVT prophylaxis (heparin, heparinoids, other anticoagulants, TEDs, SCDS) initiated by 2 nd hospital day? Yes No Not applic patient ambulating Antiplatelet/anticoagulation given within FIRST 24 hrs FIRST 48 hrs AFTER 48 hrs If yes, check all appropriate: Discharge medications Coumadin Unfractionated heparin SQ Unfractionated heparin IV LMW heparin Lovenox Treatment for atrial fibrillation: if a-fib documented, was pt discharged on anticoag? If not, give reason Risk for bleeding Risk for falls Mental status Liver disease Terminal illness Patient refused, did not want risk Patient refused, reason not specified Discontinued due to bleeding On ASA as regular medication Arthritis requiring NSAIDs or ASA Other ASA (75-325mg) Ticlid (ticlopidine) Plavix (clopidogrel) Persantine (dipyridamole) Other (specify) Yes No yes / no yes / no yes / no If not, why not: Hemorrhagic stroke Current peptic ulcer disease Intracranial surgery or biopsy Refused treatment Terminal comfort care Other (specify) Antithrombotic treatment at discharge: If yes, check all appropriate: Coumadin Unfractionated heparin SQ Unfractionated heparin IV LMW heparin Lovenox ASA (75-325mg) Ticlid (ticlopidine) Plavix (clopidogrel) Persantine (dipyridamole) Other (specify) Yes No Treatment for hypertension Cholesterol reducing treatment Treatment for diabetes None prescribed None contraindicated ACE inhibitors ARB Beta blockers Ca++ blockers Diuretics Other anti-hypertensives Anti-hypertensive diet Other lifestyle interventions: Smoking no intervention Smoking counseling Smoking medication None prescribed None contraindicated Statin Fibrate Low cholesterol diet (eg, TLC) Other Weight loss no intervention Weight loss recommended Increased activity recommended None prescribed None contraindicated Insulin Oral agents ADA diet Not applicable MD Signature: